148 related articles for article (PubMed ID: 6756445)
1. Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension.
Ikram H; Maslowski AH; Nicholls MG; Espiner EA; Hull FT
Br Heart J; 1982 Dec; 48(6):541-5. PubMed ID: 6756445
[TBL] [Abstract][Full Text] [Related]
2. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
Maslowski AH; Ikram H; Nicholls MG; Espiner EA
Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
[TBL] [Abstract][Full Text] [Related]
4. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
Atkinson AB; Brown JJ; Davies DL; Leckie B; Lever AF; Morton JJ; Robertson JI
Hypertension; 1981; 3(1):53-8. PubMed ID: 7009427
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-aldosterone and bradykinin profile in hypertension.
Mookherjee S; Anderson GH; Eich R; Hill N; Smulyan H; Streeten DH; Vardan S; Warner R
Am Heart J; 1983 Jan; 105(1):106-12. PubMed ID: 6336874
[TBL] [Abstract][Full Text] [Related]
6. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Atlas SA; Case DB; Yu ZY; Laragh JH
Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
[TBL] [Abstract][Full Text] [Related]
8. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
9. [The effect of captopril on hemodynamics in patients of chronic obstructive pulmonary disease with pulmonary hypertension].
Wang S
Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):545-8. PubMed ID: 8269786
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Lun S; Scandrett MS
J Clin Endocrinol Metab; 1981 Jun; 52(6):1253-6. PubMed ID: 7014601
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.
Fujita T; Ando K; Noda H; Sato Y; Yamashita N; Yamashita K
Am J Med; 1982 Sep; 73(3):341-7. PubMed ID: 6751080
[TBL] [Abstract][Full Text] [Related]
12. Acute haemodynamic and hormonal effects of captopril are diminished by indomethacin.
Witzgall H; Hirsch F; Scherer B; Weber PC
Clin Sci (Lond); 1982 Jun; 62(6):611-5. PubMed ID: 7044652
[TBL] [Abstract][Full Text] [Related]
13. Clinical improvement and hormonal changes in severe cardiac failure after captopril treatment.
McGrath BP; Denham IM; Johnston CI
Aust N Z J Med; 1981 Dec; 11(6):639-44. PubMed ID: 6277291
[No Abstract] [Full Text] [Related]
14. Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.
Atlas SA; Case DB; Sealey JE; Laragh JH; McKinstry DN
Hypertension; 1979; 1(3):274-80. PubMed ID: 399239
[No Abstract] [Full Text] [Related]
15. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
Atkinson AB; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():139s-143s. PubMed ID: 396067
[No Abstract] [Full Text] [Related]
16. Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.
Bauer JH
Am J Med; 1984 Aug; 77(2A):43-51. PubMed ID: 6206722
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic, hormonal, and electrolyte responses to withdrawal of long-term captopril treatment for heart failure.
Maslowski AH; Nicholls MG; Ikram H; Espiner EA; Turner JG
Lancet; 1981 Oct; 2(8253):959-61. PubMed ID: 6117729
[TBL] [Abstract][Full Text] [Related]
18. [Precapillary pulmonary hypertension: effect of Captopril].
Sanguinetti M; Galiè N; Magelli C; Orselli L; Magnani B
G Ital Cardiol; 1982; 12(6):436-41. PubMed ID: 6761221
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients.
Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
Am J Cardiol; 1980 Aug; 46(2):295-300. PubMed ID: 6250392
[No Abstract] [Full Text] [Related]
20. [Effect of captopril on hypoxia-induced pulmonary hypertension in pigs].
Chen S
Zhonghua Yi Xue Za Zhi; 1991 Mar; 71(3):150-2, 12. PubMed ID: 1648428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
